netFormulary NHS
Lancashire and South Cumbria
Formulary
 Search
 Results

Looking for Omalizumab found 11 matches
Open monograph to display formulary status BNF Category
  Omalizumab Respiratory system - Omalizumab/ Tezepelumab - 03.04.02
  Omalizumab Respiratory system - Omalizumab/ Tezepelumab - 03.04.02
  Omalizumab  (Xolair®) Skin - Drugs affecting the immune response - 13.05.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section LSCMMG: Commissioning statement Unlicensed use of omalizumab for severe chronic inducible urticarias (13.05.03)
link in drug section MHRA: Omalizumab: potential risk of arterial thrombotic events (13.05.03)
link in drug section MHRA: Omalizumab: potential risk of arterial thrombotic events (03.04.02)
link in drug section MHRA: Omalizumab: potential risk of arterial thrombotic events (03.04.02)
link in drug section NICE TA278: Omalizumab for treating severe persistent allergic asthma (03.04.02)
link in drug section NICE TA339: Omalizumab for previously treated chronic spontaneous urticaria (13.05.03)
link in drug section NICE TA678: Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) (03.04.02)

SubSection Titles / notes  
Omalizumab/ Tezepelumab - (03.04.02)



Document Library Items Found

 
netFormulary